• Information Notes - Third Parties
• Information Notes - 59 Third Party Objections
• Information Notes - 60(1)(a) Decision to Release
• Information Notes - Must vs. May
• Guidance Document: Drug Submissions Relying on Third-Party Data (Literature and Market Experience)